In early April 2025, a delegation from a leading Indian diagnostics company – including DGM and Chief Scientific Advisor, visited YZY Med. This Indian company specializes in cutting-edge clinical diagnostic solutions for central laboratories, hospitals, and home testing. Both parties discussed the cooperation on Automatic FISH Slide Processing System F902, also had in-depth discussion on the complete solution of CTC device. As an important part of the globalization strategy, this cooperation will use India as a pivot, then radiate to emerging markets such as Middle East and Southeast Asia in the future.
Automatic FISH Slide Processing System F902 adopts intelligent operation design, supports parallel processing of multiple samples, it significantly improves experimental efficiency and result consistency, and provides fast and accurate detection support for clinical practice. Moreover, CTC Separator (D200 A10) is expected to fill the gap in the field of circulating tumor cell detection in emerging markets, and assist in early screening and dynamic monitoring of cancer.
The innovative technology matrix of YZY Med includes automated CTC separation, high-precision FISH device and customized probe solutions，qPCR kits. All these will further promote the universal application of precision medical technology on cancer/tumor and reduce regional medical costs. YZY will continue to deepen cooperation with international partners, and through technology sharing and ecological co-construction, help upgrade and iterate the global cancer diagnosis and treatment system!
During high-level discussions, both parties explored collaboration opportunities for the YZYF902 fully automated FISH system and comprehensive CTC (Circulating Tumor Cell) detection solutions.
